 Daily Mail |
GSK vows to stick by controversial diabetes drug
Daily Mail Pharmaceuticals giant Glaxo SmithKline (GSK) has pledged to stick by its controversial blockbuster diabetes drug Avandia, after it was branded unfit for sale by a British regulator. The drug was GSK's second biggest seller, before a study … Medical Journal Urges UK to Pull Diabetes Drug Avandia UK regulators want Avandia diabetes pill pulled BBC Panorama – 6 September 2010: “A Risk Worth Taking?” Programme … |
View full post on Health – Google News
